Left Ventricular Dysfunction in Cancer Treatment: Is it Relevant?. [Review] (Record no. 3104)

MARC details
000 -LEADER
fixed length control field 02724nam a22003377a 4500
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 180220s20182018 xxu||||| |||| 00| 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 2213-1779
024 ## - OTHER STANDARD IDENTIFIER
Standard number or code 10.1016/j.jchf.2017.08.024 [doi]
024 ## - OTHER STANDARD IDENTIFIER
Standard number or code S2213-1779(17)30622-4 [pii]
040 ## - CATALOGING SOURCE
Original cataloging agency Ovid MEDLINE(R)
099 ## - LOCAL FREE-TEXT CALL NUMBER (OCLC)
PMID 29413379
245 ## - TITLE STATEMENT
Title Left Ventricular Dysfunction in Cancer Treatment: Is it Relevant?. [Review]
251 ## - Source
Source JACC Heart Failure. 6(2):87-95, 2018 Feb
252 ## - Abbreviated Source
Abbreviated source JACC Heart Fail. 6(2):87-95, 2018 Feb
253 ## - Journal Name
Journal name JACC. Heart failure
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Year 2018
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Manufacturer FY2018
266 ## - Date added to catalog
Date added to catalog 2018-02-20
520 ## - SUMMARY, ETC.
Abstract Contemporary cancer therapies have dramatically improved cancer-free and overall survival but have been accompanied by increasing cancer treatment-related cardiovascular toxicity, including left ventricular (LV) systolic dysfunction. Previously, systemic chemotherapy with anthracyclines and radiation therapy were the only cancer treatments with significant cardiotoxicity. However, modern targeted cancer therapies, including HER2 inhibitors, tyrosine kinase inhibitors (TKIs), proteasome inhibitors, and immune checkpoint inhibitors, have all been associated with adverse cardiovascular events. As cancer treatment paradigms successfully move toward prolonged targeted therapy, cardiologists are increasingly needed to assess cardiotoxicity risk and manage asymptomatic and symptomatic LV systolic dysfunction. This state of the art review summarizes the present knowledge about the mechanisms and clinical practices of screening, diagnosis, and management of LV dysfunction associated with cancer therapeutic regimens. We utilize the framework of the ACCF/AHA stages of heart failure (HF) to summarize current evidence for risk stratification and modification (Stage A HF), asymptomatic structural heart disease detection and treatment (Stage B HF), and reduction of HF morbidity and mortality (Stages C and D HF) during cancer treatment and in survivorship. We also present new clinical practice challenges and opportunities for active engagement of cardiologists with multidisciplinary cancer treatment teams in order to ensure optimal patient outcomes.
520 ## - SUMMARY, ETC.
Abstract Copyright (c) 2018 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
546 ## - LANGUAGE NOTE
Language note English
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element IN PROCESS -- NOT YET INDEXED
651 ## - SUBJECT ADDED ENTRY--GEOGRAPHIC NAME
Institution MedStar Heart & Vascular Institute
657 ## - INDEX TERM--FUNCTION
Medline publication type Journal Article
657 ## - INDEX TERM--FUNCTION
Medline publication type Review
700 ## - ADDED ENTRY--PERSONAL NAME
Local Authors Barac, Ana
700 ## - ADDED ENTRY--PERSONAL NAME
Local Authors Kenigsberg, Benjamin
790 ## - Authors
All authors Barac A, Kenigsberg B, Wellstein A
856 ## - ELECTRONIC LOCATION AND ACCESS
DOI <a href="https://dx.doi.org/10.1016/j.jchf.2017.08.024">https://dx.doi.org/10.1016/j.jchf.2017.08.024</a>
Public note https://dx.doi.org/10.1016/j.jchf.2017.08.024
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Koha item type Journal Article
Item type description Article
Holdings
Withdrawn status Lost status Damaged status Not for loan Collection Home library Current library Date acquired Total Checkouts Full call number Barcode Date last seen Price effective from Koha item type
          MedStar Authors Catalog MedStar Authors Catalog 02/20/2018   29413379 29413379 02/20/2018 02/20/2018 Journal Article

Powered by Koha